IVIM Health vs BreezeMeds: Compounded GLP-1 Pricing and Features
Quick verdict: IVIM Health vs BreezeMeds
IVIM Health vs BreezeMeds favors IVIM for third-party ratings and a lower advertised compounding entry price, while BreezeMeds lists higher starting prices and both injectable and oral options. Early verdict: choose IVIM if third-party ratings and a free-month offer matter; choose BreezeMeds if you need clearly listed injectable and oral product starts.
See IVIM Health free-month offer
How these providers differ: key comparison points
This comparison focuses on five distinctive differences supported by the sources: starting price and promotions, third-party ratings and trust signals, product formats and compounding status, pricing transparency and ranges, and program or protocol claims.
1. Starting price and promotions
IVIM Health advertises compounded semaglutide at $75/mo and notes a Limited Offer: Free Month Membership with code GIFT75. BreezeMeds displays semaglutide injection starting at $199/mo, tirzepatide injection starting at $299, and oral options from $399, with a separate $169 figure shown without clear product association.
Start IVIM Health with code GIFT75
2. Third-party ratings and trust signals
IVIM Health is presented as having a 4.9-star rating on both Google and Trustpilot, a highlighted trust signal in the source. BreezeMeds does not show third-party ratings in the captured evidence; the source emphasizes discreet shipping and online intake instead.
3. Product formats and compounding status
Both sources reference compounded options. IVIM explicitly states its offerings are compounded and clarifies that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds lists injectable and oral semaglutide and tirzepatide options and notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
4. Pricing transparency and range
IVIM provides specific pricing lines for semaglutide ($75/mo) and tirzepatide ($133/mo) plus a $74.99/mo program fee in the captured landing-page text and a separate FAQ saying first month $99 and $174/month ongoing. BreezeMeds shows multiple starting prices across product types (starting at $199, $299, $399) and a separate $169 figure without a clear product association, and the source asks users to confirm eligibility, total cost and state availability.
5. Protocols, claims, and clinical notes
IVIM cites a proprietary GLP-1 ID protocol claiming up to 40% faster weight loss versus a published GLP-1 trial and references published retrospective observational studies; the source preserves that this is not a head-to-head trial and the 40% figure is IVIM’s own protocol claim. BreezeMeds does not present comparative outcome claims in the captured evidence and focuses on intake, personalized plans, and discreet delivery.
Comparison table: IVIM Health vs BreezeMeds
| Criteria | IVIM Health | BreezeMeds |
|---|---|---|
| Starting price shown | $75/mo (compounded semaglutide listed) | Semaglutide injection from $199/mo; tirzepatide injection from $299; oral from $399 |
| Promotions | Free Month Membership with code GIFT75; no-obligation free consult ($75 value) | No clear promotional code captured; multiple starting prices visible |
| Third-party ratings | 4.9-star on Google and Trustpilot (listed) | No third-party ratings captured |
| Product formats | Compounded semaglutide and tirzepatide (compounded only) | Injectable and oral semaglutide and tirzepatide listed; compounding status requires confirmation |
| Regulatory note | Compounded medications not FDA-approved; not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; branded and compounded not interchangeable |
| Program claims | Proprietary GLP-1 ID protocol claiming up to 40% faster weight loss; internal and observational studies cited | No comparable outcome claim captured |
What is not supplied in the sources
The captured evidence does not provide complete fee schedules, state-by-state availability details, full FAQ text for BreezeMeds, or direct comparisons of clinical outcomes between the two providers beyond IVIM’s internal and observational study references. Insurance acceptance details beyond IVIM’s direct-pay statement were not supplied for BreezeMeds.
View BreezeMeds treatment starts
Final thoughts and choosing between them
IVIM Health vs BreezeMeds narrows to priorities: IVIM highlights lower advertised entry pricing for compounded semaglutide, a free-month code GIFT75, and unusually strong third-party ratings. BreezeMeds lists higher starting prices across injectables and oral options and emphasizes online intake and discreet home delivery, but the $169 figure and some fee details were not clearly tied to specific products in the captured evidence.
Check BreezeMeds product options
Choose IVIM Health if you value a free-month promotion, a no-obligation $75 consultation included for new patients, and the provider’s dual 4.9-star ratings. Choose BreezeMeds if you need clearly listed injectable and oral starting prices and want to confirm specific product starts, eligibility, and state availability before enrolling. Mentioned claims and pricing are those captured from each provider and are subject to the qualifiers and regulatory notes provided by the sources.